✦ LIBER ✦

Toxicity of interferon and interleukin

✍ Scribed by Karl Fent; Gerhard Zbinden

Book ID: 119111965
Publisher: Elsevier Science
Year: 1987
Tongue: English
Weight: 849 KB
Volume: 8
Category: Article
ISSN: 0165-6147
DOI: 10.1016/0165-6147(87)90083-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A progress report of a phase I study of

A progress report of a phase I study of interferon-gamma and interleukin-2 and some comments on the mechanism of the toxicity due to interleukin-2

✍ Wagstaff, J.; Vermorken, J.B.; Schwartsmann, G.; Scheper, R.J.; Hack, C.E.; Nuij 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 296 KB

Production of tumor necrosis factor α an

Production of tumor necrosis factor α and interferon γ in interleukin-2-treated melanoma patients: Correlation with clinical toxicity

✍ James S. Economou; Mary Hoban; Jeffrey D. Lee; Richard Essner; Stephen Swisher; 📂 Article 📅 1991 🏛 Springer-Verlag 🌐 English ⚖ 548 KB

Recombinant interleukin-2 and recombinan

Recombinant interleukin-2 and recombinant interferon α immunotherapy cardiovascular toxicity

✍ D. Schechter; A. Nagler 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 429 KB

"TOXICITY" OF INTERFERON

✍ Johansson, Magnus B.N.; Karlsson, Börje W. 📂 Article 📅 1983 🏛 The Lancet 🌐 English ⚖ 162 KB

Pharmaceutical Biotechnology || Interfer

Pharmaceutical Biotechnology || Interferons and Interleukins

✍ Crommelin, Daan J. A.; Sindelar, Robert D.; Meibohm, Bernd 📂 Article 📅 2013 🏛 Springer New York 🌐 English ⚖ 730 KB

This introductory text explains both the basic science and the applications of biotechnology-derived pharmaceuticals, with special emphasis on their clinical use. It serves as a complete one-stop source for undergraduate/graduate pharmacists, pharmaceutical science students, and for those in the pha

Interferon, Interleukin-2, and Other Cyt

Interferon, Interleukin-2, and Other Cytokines

✍ Buchbinder, Elizabeth I.; McDermott, David F. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 391 KB